In short, Anne-Roos Schrader's research entails the following:
Artificial Intelligence for Diagnosis of Cutaneous Lymphomas – the AID-CLYM study
Cutaneous lymphoma (CL) is a rare and heterogeneous group of hematological skin cancers that is largely distinct from its systemic counterparts in clinical presentation, histopathology, and biological behavior. Therefore, CLs require different therapeutical management. For correct classification and therapeutic management, patients with (suspicion of) CL need timely referral to an expert center. In most CL subtypes, however, diagnosis is challenging and cases are easily mistaken for inflammatory dermatoses, such as eczema or drug reactions.
Recent studies demonstrated that artificial intelligence (AI) is capable of recognizing patterns in digital pathology images and that these can be used to generate computer-based predictions. This novel AI-based approach, however, has not yet been studied in diagnosis of CL patients. With the funding by the Hanarth Fonds, the departments of Pathology and Dermatology of the Leiden University Medical Center (LUMC), the national referral center for patients with CL, will study whether artificial intelligence can improve the process of referral and diagnostics for patients with these rare variants of skin cancer. For this project, the LUMC will collaborate with the Leiden Institute of Computer Science (LIACS).